Md Anwarul Azim Majumder, Afzalunnessa Binte Lutfor, Ahbab Mohammad Fazle Rabbi, A B M Muksudul Alam, Mizanur Rahman, Narayan Saha, Michael H Campbell, Mainul Haque, Kamrun Nessa, Mohib Ullah Khondoker, Tapas Ranjan Das, Sayeeda Rahman, Fauzia Jahan, Saidur Rahman Mashreky, Abrar Wahab, Md Tosaddeque Hossain Siddiqui, Karisha Hinkson-Lacorbiniere, Roksana Ivy, Rezaul Islam, Yusuf Haider, Eliza Omar, S M Moslehuddin Ahmed, A M Selim Reza, A K M Daud, Muiz Uddin Ahmed Choudhury, Md Abed Hossain, Abdul Matin Pappu, Nusrat Jahan, Mohammed S Razzaque
Increased COVID-19 vaccine hesitancy presents a major hurdle in global efforts to contain the COVID-19 pandemic. This study was designed to estimate the prevalence of adverse events after the first dose of the Covishield (AstraZeneca) vaccine among physicians in Bangladesh. A cross-sectional study was conducted using an online questionnaire for physicians ( n = 916) in Bangladesh. Physicians who received at least one dose of the COVID-19 vaccine were included. The study was carried out from April 12 to May 31, 2021...
March 24, 2022: FASEB BioAdvances